Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Ascending Dose Pharmacokinetics and Safety of Solriamfetol in Pediatric Narcolepsy
2019-003008-11Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of solriamfetol in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Primary endpoints: Efficacy (wakefulness) and Pharmacokinetics of solriamfetol. Started May 2020; status: completed.
02
Drugs
solriamfetol
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2019-003008-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003008-11.